3 results match your criteria: "Hospital e Maternidade Celso Pierro-PUC[Affiliation]"
Importance: Immune dysregulation contributes to poorer outcomes in COVID-19.
Objective: To investigate whether abatacept, cenicriviroc, or infliximab provides benefit when added to standard care for COVID-19 pneumonia.
Design, Setting, And Participants: Randomized, double-masked, placebo-controlled clinical trial using a master protocol to investigate immunomodulators added to standard care for treatment of participants hospitalized with COVID-19 pneumonia.
Arq Bras Endocrinol Metabol
March 2007
Departamento de Clínica Médica, Faculdade de Medicina de Ribeirão Preto, USP, São Paulo, and Laboratório de Hemodinâmica e Cardiologia Intervencionista, Hospital e Maternidade Celso Pierro-PUC, Campinas, SP, Brazil.
Cochrane Database Syst Rev
September 2003
Hospital e Maternidade Celso Pierro/PUC-Campinas e Instituto do Radium de Campinas, Av Heitor Penteado 1780, Campinas, Sao Paulo, Brazil.
Background: Febrile neutropenia is a frequent event for cancer patients undergoing chemotherapy and it is potentially a life threatening situation. The current treatment is supportive care plus antibiotics. Colony stimulating factors (CSF) are cytokines that stimulate and accelerate the production of one or more cellular lines in bone marrow.
View Article and Find Full Text PDF